Phillip E. Barnette, M.D., D.V.M.

Locations

Schedule An Appointment	Clinical Office Address
(801) 662-4700	Primary Children's Hospital Pediatric Hematology/Oncology 100 N Mario Capecchi Drive Salt Lake City, UT 84113

Bio

Phillip Barnette, MD, DVM, is an associate professor in the University of Utah School of Medicine and a member of the Experimental Therapeutics Program at Huntsman Cancer Institute. He is a pediatric oncologist-hematologist.

Barnette is interested in the study of acute childhood leukemia, clinical trials of leukemia, and research and therapeutic advances in childhood leukemia.

He received both a bachelor's of science and doctorate of veterinary medicine degree at Oregon State University, Corvallis. He received a medical degree at Oregon Health Sciences University, Portland.

Board Certification and Academic Information

Academic Departments	Pediatrics - Associate Professor (Clinical)
Academic Divisions	Pediatric Hematology/Oncology
Board Certification	American Board of Pediatrics (Pediatrics)
Cancer Center Programs	Experimental Therapeutics

Board Certification and Academic Information

Academic Departments	Pediatrics - Associate Professor (Clinical)
Academic Divisions	Pediatric Hematology/Oncology
Board Certification	American Board of Pediatrics (Pediatrics)
Cancer Center Programs	Experimental Therapeutics

Academic Office Locations

Academic Office Phone Number	Academic Office Address
(801) 662-4700	Primary Children's Hospital 100 N Mario Capecchi Drive Salt Lake City, UT 84113

Academic Bio

Dr. Barnette received his medical degree at Oregon Health and Sciences University, and completed his pediatric residency at Doernbecher Children's Hospital in Portland, Oregon. His fellowship training was completed at the University of Utah.

He joined the faculty of the University of Utah in 2003, where he is currently an Associate Professor of Pediatrics in the Division of Pediatric Hematology and Oncology. He is board certified in General Pediatrics and Pediatric Hematology/Oncology. He is a member of the Experimental Therapeutics Program.

His clinical and research interests include high risk acute leukemias and the underlying genetic basis of leukemogenesis. He also has an interest in clinical trials and process improvement. He serves as the institional Principal Investigator for the Children's Oncology Group.

Education History

Type	School	Degree
Fellowship	University of Utah School of Medicine Pediatric Hematology/Oncology	Fellow
Residency	Oregon Health Sciences University Pediatrics	Resident
Professional Medical	Oregon Health Sciences University Medicine	M.D.
Professional Other	Oregon State University Veterinary Medicine	D.V.M.
Undergraduate	Oregon State University Animal Biology	B.S.

Selected Provider Publications

Journal Article

1. Leventaki V, Rodic V, Tripp SR, Bayerl MG, Perkins SL, Barnette P, Schiffman JD, Miles R(2012)TP53 pathway analysis in paeditric Burkitt lymphoma reveals increased MDM4 expression as the only TP53 abnormality detected in a subset of cases.  British Journal of Haematology, 158(6),763-71

Clinical Trials

• COG ANHL1131
  Keywords: B-Cell NHL, Burkitt leukaemia, Rituximab, Burkitt lymphoma
  Status: Not yet recruiting Principal Investigator: Phillip Barnette